Architecture of the Vimentin Cytoskeleton is Modified by Perturbation of the Gtpase Arf1.
From: Graduate Program in Biochemistry, Cell, and Developmental Biology, Emory University, Atlanta, GA 30322, USA.
Journal of cell science
- Publish Date: Sep 2006
- ISSN: 0021-9533
- Volume: 119
- Issue: Pt 17
- Pages: 3643-54
- Medium: Print
- Language: English
- Citation (JAMA): Styers Melanie L, Kowalczyk Andrew P, Faundez Victor, et al. Architecture of the Vimentin Cytoskeleton is Modified by Perturbation of the Gtpase Arf1.. J. Cell. Sci. Sep 2006;119:3643-54
Abstract
Intermediate filaments are required for proper membrane protein trafficking. However, it remains unclear whether perturbations in vesicular membrane transport result in changes in the architecture of the vimentin cytoskeleton. We find that treatment of cells with Brefeldin A, an inhibitor of specific stages of membrane transport, causes changes in the organization of vimentin filaments. These changes arise from movement of pre-existing filaments. Brefeldin A treatment also leads to alterations in the microtubule cytoskeleton. However, this effect is not observed in cells lacking intermediate filaments, indicating that microtubule bundling is downstream of perturbations in the vimentin cytoskeleton. Brefeldin A-induced changes in vimentin architecture are probably mediated through its effects on ADP-ribosylation factor 1 (ARF1). Expression of a dominant-negative mutant of ARF1 induces BFA-like modifications in vimentin morphology. The BFA-dependent changes in vimentin architecture occurred concurrently with the release of the ARF1-regulated adaptor complexes AP-3 and AP-1 from membranes and adaptor redistribution to vimentin networks. These observations indicate that perturbation of the vesicular membrane transport machinery lead to reciprocal changes in the architecture of vimentin networks.
Mesh Headings (Keywords): ADP-Ribosylation Factor 1, Adenosine Diphosphate, Animals, Biological Transport, Brefeldin A, Cell Line, Cell Membrane, Cell Shape, Cytoskeleton, Golgi Apparatus, Humans, Microtubules, Protein Synthesis Inhibitors, Vimentin
Check for Full Text / PubMed Unique Identifier (PMID): 16912072
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.